Gilead Sciences to Present at the 25th Annual JPMorgan Healthcare Conference on Monday, January 8th.Webcast Available Through Gilead Corporate Website FOSTER CITY, Calif. -- Gilead Sciences Gilead Sciences NASDAQ: GILD is a biopharmaceutical company that discovers, develops and commercializes therapeutics to advance the care of patients suffering from life-threatening diseases. , Inc. (Nasdaq:GILD) announced today that its corporate presentation will be webcast from the 25th Annual JPMorgan Healthcare Conference, in San Francisco San Francisco (săn frănsĭs`kō), city (1990 pop. 723,959), coextensive with San Francisco co., W Calif., on the tip of a peninsula between the Pacific Ocean and San Francisco Bay, which are connected by the strait known as the Golden , CA. This webcast may be accessed via the company's corporate website at www.gilead.com. John Martin, PhD, Gilead's President and Chief Executive Officer, will provide an overview of the company on Monday, January 8th at 8:30 a.m. Pacific Time (11:30 p.m. Eastern Time). To access the live webcast via the internet log on to www.gilead.com. Please connect to the company's website at least 15 minutes prior to the live presentation to ensure adequate time for any software download that may be necessary to listen to the webcast. About Gilead Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California
For more information on Gilead Sciences, please visit www.gilead.com or call the Gilead Public Affairs Those public information, command information, and community relations activities directed toward both the external and internal publics with interest in the Department of Defense. Also called PA. See also command information; community relations; public information. Department at 1-800-GILEAD-5 (1-800-445-3235). |
|
||||||||||||||

Printer friendly
Cite/link
Email
Feedback
Reader Opinion